Cancer & Metabolism welcomes studies on all aspects of the relationship between cancer including molecular biology and genetics. The journal is indexed in DOAJ, Emerging Sources Citation Index (ESCI), PubMed, and PubMed Central.
Learn more
Advertisement
We are delighted to announce Cancer & Metabolism's first Impact Factor is 5.033!
Thank you to our Editors-in-Chief Dr. Michael Pollak and Dr. Matthew G. Vander Heiden for their hard work and to all those who support this journal.
Download Panda VPN - free - latest version:Download Panda VPN for Windows now from Softonic: 100% safe and virus free. More than 1690 downloads this month. Download Panda VPN latest version 2021
Cancer & Metabolism welcomes studies on all aspects of the relationship between cancer including molecular biology and genetics. The journal is indexed in DOAJ, Emerging Sources Citation Index (ESCI), PubMed, and PubMed Central.
Learn more
Dr. Michael Pollak, co-Editor-in-Chief
Dr. Pollak is an internationally recognized expert in cancer endocrinology at the Lady Davis Institute for Medical Research of McGill University and a clinical oncologist at the Jewish General Hospital, Quebec, Canada.
"Cancer & Metabolism will provide a forum for rapid dissemination of research findings concerning metabolic factors that influence cancer risk and cancer pathophysiology, and cancer treatment. The scope of the Journal will allow for an interdisciplinary readership including cancer biologists, endocrinologists, oncologists, clinical trialists and population scientists."
Dr. Matthew G. Vander Heiden, co-Editor-in-Chief
Dr. Vander Heiden is Associate Director at the Koch Institute for Integrative Cancer Research at MIT. Extensively published in over 140 peer reviewed articles and book chapters, his research interests focus on the metabolic processes of cancer cells, including how glucose metabolism affects tumor growth and how these studies may lead to new developments in targeted cancer therapy. A renowned innovative researcher in his field, Dr. Vander Heiden received the 2017 Philip A. Sharp Innovation in Collaboration Award from Stand Up to Cancer (SU2C).
Associate Editors:
老王vpm2.2.11下载安卓版, 老王vpm2.2.11下载安卓版
Navdeep Chandel, Northwestern University, USA
老王vpm2.2.11下载安卓版, Browse Android Software - Download.com:ToTok - Free HD Video Calls & Voice Chats Free VIEW →. Communicate with family and friends anywhere, anytime, with encrypted messaging and video calling.
熊猫ⅤPN安卓
Abass Alavi, University of Pennsylvania School of Medicine, USA
Lewis Cantley, Weill Cornell Medical College, USA
Peter Carmeliet, Vesalius Research Center, Belgium
Teresa Fan, Markey Cancer Center, USA
Robert Gatenby, H. Lee Moffitt Cancer Center and Research Institute, USA
Kun-Liang Guan, University of California, San Diego, USA
Rudolf Kaaks, German Cancer Research Center, Germany
Andrew Lane, Markey Cancer Center, USA
熊猫ⅴpn安卓下载, University of Texas M. D. Anderson Cancer Center, USA
Jacques Pouyssegur, Institute of Research on Cancer and Aging, France
Joshua Rabinowitz, Princeton University, USA
SuPerⅤPN, High Performance Network Proxy - LadderVPN:100+ Servers Worldwide! Try our App Proxy FOR FREE!
Jeffrey Rathmell, Duke University, USA
熊猫pn, VPN服务商AnchorFree获高盛投资5200万美元_科技滚动 ...:2021-5-22 · 网易科技讯 5月21日消息,据国外媒体报道,世界著名虚拟私人网络VPN开发者AnchorFree结束了本轮由高盛领投的C系列融资计划。融资金额5200万美元。 该公司主打产品热点盾(Hotspot Shield)深受广大用户喜爱,每一亿次的访问量即可达到 ...
David Sabatini, Whitehead Institute for Biomedical Research, USA
Paolo Sassone-Corsi, University of California, Irvine, USA
Gregg Semenza, Johns Hopkins University School of Medicine, USA
Celeste Simon, University of Pennsylvania School of Medicine, USA
Alexei Vazquez, The Cancer Institute of New Jersey, USA
Bert Vogelstein, Johns Hopkins University School of Medicine, USA
Karen Vousden, Beatson Institute for Cancer Research, UK
Kathryn Wellen, University of Pennsylvania, USA
Eileen White, The Cancer Institute of New Jersey, USA
Yue Xiong家中看“黄片”是否违法?-中国法院网 - chinacourt.org:2021-3-25 · 【案情】2021年8月,刘某在家中电脑上观看“黄片”, 三名民警突然造访,称其违反《计算机信息网络国际互联网安全保护管理办法》第五条第六项和第二十条,对其罚款1000元。
Most recent articles RSS
View all articles
Most accessed articles RSS
View all articles
The biology of tumor cells in breast cancer is complex and relatively unexplored. Cancer & Metabolism is excited to present the following article highlights that identify novel biomarkers and metabolic profiles of different breast cancer subtypes.
- Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities
- Metabolomics of oncogene-specific metabolic reprogramming during breast cancer
- Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation
- Activation of pro-survival metabolic networks by 1,25(OH)2D3 does not hamper the sensitivity of breast cancer cells to chemotherapeutics
- 男子因出售VPN被判有期徒刑三年 罚金10000元-中国法院网 ...:2021-10-9 · 近日,上海市宝山区人民法院依法公开开庭宣判被告人戴某提供侵入、非法控制计算机信息系统程序、工具罪一案,判处有期徒刑三年,缓刑三年,并处罚金人民币一万元。
Chi Van Dang, Editor Emeritus
Chi Dang is a professor, physician-researcher, renowned cancer biologist and hematologist-oncologist, who serves as director of the Abramson Cancer Center at the University of Pennsylvania.
"After several decades of profound advances in our understanding of the genetics and molecular biology of cancer, it has become self-evident that metabolism and bioenergetics are regulated by cancer genes and are intimately linked to the growth and survival of cancer cells. The obesity pandemic connected to increased cancer risk further underscore the importance of a richer understanding of cancer and organismal metabolism. In this regard, Cancer & Metabolism is launched uniquely to fulfill the needs of a burgeoning field which is at the crossroads of many scientific disciplines."
Advertisement
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our usual peer review process. We thank referees for their continued support in these challenging times and ask authors for their patience and understanding.
Thumbnail image by Felipe Esquivel Reed, used under Creative Commons Attribution-Share Alike 4.0 license.
Speed
65 days to first decision for reviewed manuscripts only
59 days to first decision for all manuscripts
135 days from submission to acceptance
35 days from acceptance to publication
panda v pn下载 android
5.033 - 2 Year Impact Factor
0.583 - Immediacy Index
Usage
140,853 Downloads
210 Altmetric Mentions
Advertisement